Skip to main content
Journal cover image

RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH

Publication ,  Journal Article
Klink, JC; Poulton, S; Antonelli, J; Potter, MQ; Jayachandran, J; Tewari, AK; Febbo, PG; Pizzo, SV; Freedland, SJ
Published in: Journal of Urology
April 2009

Duke Scholars

Published In

Journal of Urology

DOI

EISSN

1527-3792

ISSN

0022-5347

Publication Date

April 2009

Volume

181

Issue

4S

Start / End Page

259 / 259

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Klink, J. C., Poulton, S., Antonelli, J., Potter, M. Q., Jayachandran, J., Tewari, A. K., … Freedland, S. J. (2009). RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH. Journal of Urology, 181(4S), 259–259. https://doi.org/10.1016/s0022-5347(09)60738-2
Klink, Joseph C., Susan Poulton, Jodi Antonelli, Michael Q. Potter, Jayakrishnan Jayachandran, Alok K. Tewari, Phillip G. Febbo, Salvatore V. Pizzo, and Stephen J. Freedland. “RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH.” Journal of Urology 181, no. 4S (April 2009): 259–259. https://doi.org/10.1016/s0022-5347(09)60738-2.
Klink JC, Poulton S, Antonelli J, Potter MQ, Jayachandran J, Tewari AK, et al. RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH. Journal of Urology. 2009 Apr;181(4S):259–259.
Klink, Joseph C., et al. “RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH.” Journal of Urology, vol. 181, no. 4S, Ovid Technologies (Wolters Kluwer Health), Apr. 2009, pp. 259–259. Crossref, doi:10.1016/s0022-5347(09)60738-2.
Klink JC, Poulton S, Antonelli J, Potter MQ, Jayachandran J, Tewari AK, Febbo PG, Pizzo SV, Freedland SJ. RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2009 Apr;181(4S):259–259.
Journal cover image

Published In

Journal of Urology

DOI

EISSN

1527-3792

ISSN

0022-5347

Publication Date

April 2009

Volume

181

Issue

4S

Start / End Page

259 / 259

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences